Event: 2026 AMWA Webinar
Date: Thursday, April 16
Time: 1:00 PM - 2:00 PM ET
Location: Online (Live Webinar)
Invitation:
The American Medical Writers Association (AMWA) is the resource for professional medical communicators, promoting excellence in medical communication and providing educational resources in support of that goal. Founded in 1940, AMWA is the leading professional organization for writers, editors, and other communicators of medical information.
Webinar Information：
Topic：Faster AI-Augmented Draft-to-Submission for Clinical Documents: Live AI Demos
Discover how AI can help you move faster from draft to submission for critical clinical and regulatory documents. In this live, demo-driven webinar, you’ll see practical AI workflows across protocols, CSRs, CTD clinical overviews and summaries, and DSUR/PBRER reports. You’ll learn how AI can cut authoring time, support high-quality first drafts, streamline review and quality control, and use change intelligence across a document network to manage updates more efficiently—while keeping writers firmly in control of content and compliance. Attendees will gain practical insights to support faster, more efficient clinical document authoring across the R&D lifecycle.
Register：https://www.amwa.org/events/EventDetails.aspx?id=2046606&group=
Learning Objectives:
By the end of this webinar, participants will be able to:
Identify where AI can reduce effort and cycle time across clinical documents, accelerating the path from first draft to submission.
Apply practical AI workflows to protocols, CSRs, CTD clinical overviews, and DSUR/PBRER documents from drafting through final QC.
Use AI-driven change intelligence across document networks to maintain cross-document consistency and manage updates more efficiently.
Outline：
Where AI delivers the greatest efficiency gains in clinical document authoring workflows
Live AI demos across key clinical documents, including protocols, CSRs, CTD clinical summaries, and DSUR/PBRER
Broader opportunities for AI-powered authoring across the R&D document lifecycle.
Target Audience：
Designed for medical writers, regulatory writers, and clinical documentation professionals involved in developing clinical and submission documents who want to learn practical AI tools to accelerate draft-to-submission authoring workflows.
About the Presenters:
Sharon Chen, Founder and CEO, AlphaLife Sciences.
Sharon Chen founded AlphaLife Sciences to bring enterprise-grade AI to drug development—specifically to the complex, compliance-driven world of regulatory and clinical authoring. She brings over 30 years of software engineering leadership experience, including roles as Asia Pacific General Manager at Verily Life Sciences (Alphabet) and Engineering Director at Google, where she received the Founder’s Award and the Outstanding Leadership Award. Sharon’s rare combination of deep technical expertise and life sciences domain knowledge shapes AlphaLife’s approach to building AI that regulated teams can deploy and trust in real-world environments.
Will Chen, Head of Solution, AlphaLife Sciences.
Will Chen is Head of Solutions at AlphaLife Sciences, where he leads the design and deployment of AI-driven solutions to transform clinical development and life sciences workflows. He specializes in translating complex scientific and regulatory challenges into scalable, commercially viable digital platforms. With more than 15 years of experience at the intersection of healthcare, data, and strategy, Will has held leadership roles at McKinsey & Company, Elsevier, and Syapse, driving growth and operational transformation across the pharmaceutical sector. He holds a Ph.D. in Genetics from Stanford University School of Medicine and a B.S. in Biology from MIT.
To request a meeting, fill out the form provided and a representative will be in contact soon to schedule.
